Allscripts (MDRX) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Allscripts announces third quarter 2018 results
November 1, 2018 4:01 PM EDTReported third quarter growth of 16% in GAAP revenue to $522 million, 19% in non-GAAP revenue to $536 millionThird quarter GAAP loss per share of $0.20, growth of 13% in non-GAAP EPS to $0.18Year-to-date growth of 21% in GAAP revenue to $1,562 million, 23% in non-GAAP revenue to $1,590 millionYear-to-date GAAP loss per share of $0.06, growth of 18% in non-GAAP EPS to $0.52
CHICAGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2018.
Third... More
